COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020.
Emerg Infect Dis
; 26(10): 2513-2515, 2020 Oct.
Article
in English
| MEDLINE | ID: covidwho-623269
ABSTRACT
Because of in vitro studies, hydroxychloroquine has been evaluated as a preexposure or postexposure prophylaxis for coronavirus disease (COVID-19) and as a possible COVID-19 curative treatment. We report a case of COVID-19 in a patient with sarcoidosis who was receiving long-term hydroxychloroquine treatment and contracted COVID-19 despite adequate plasma concentrations.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Sarcoidosis, Pulmonary
/
Coronavirus Infections
/
Hydroxychloroquine
/
Antimalarials
Type of study:
Case report
/
Diagnostic study
/
Experimental Studies
Topics:
Long Covid
Limits:
Adult
/
Humans
/
Male
Country/Region as subject:
Europa
Language:
English
Journal:
Emerg Infect Dis
Journal subject:
Communicable Diseases
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS